|
1
|
Chandran V and Raychaudhuri SP:
Geoepidemiology and environmental factors of psoriasis and
psoriatic arthritis. J Autoimmun. 34:J314–J321. 2010.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Munz OH, Sela S, Baker BS, Griffiths CE,
Powles AV and Fry L: Evidence for the presence of bacteria in the
blood of psoriasis patients. Arch Dermatol Res. 302:495–498.
2010.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Rademaker M, Agnew K, Anagnostou N,
Andrews M, Armour K, Baker C, Foley P, Gebauer K, Gupta M, Marshman
G, et al: Psoriasis and infection. A clinical practice narrative.
Australas J Dermatol. 60:91–98. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Norrlind R: The significance of infections
in the origination of psoriasis. Acta Rheumatol Scand. 1:135–144.
1955.PubMed/NCBI
|
|
5
|
Mallon E, Bunce M, Savoie H, Rowe A,
Newson R, Gotch F and Bunker CB: HLA-C and guttate psoriasis. Br J
Dermatol. 143:1177–1182. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gudjonsson JE, Thorarinsson AM,
Sigurgeirsson B, Kristinsson KG and Valdimarsson H: Streptococcal
throat infections and exacerbation of chronic plaque psoriasis: A
prospective study. Br J Dermatol. 149:530–534. 2003.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Valdimarsson H, Thorleifsdottir RH,
Sigurdardottir SL, Gudjonsson JE and Johnston A: Psoriasis-as an
autoimmune disease caused by molecular mimicry. Trends Immunol.
30:494–501. 2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Sigurdardottir SL, Thorleifsdottir RH,
Valdimarsson H and Johnston A: The association of sore throat and
psoriasis might be explained by histologically distinctive tonsils
and increased expression of skin-homing molecules by tonsil T
cells. Clin Exp Immunol. 174:139–151. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Nardo AD, Vitiello A and Gallo RL: Cutting
Edge: Mast cell antimicrobial activity is mediated by expression of
cathelicidin antimicrobial peptide. J Immunol. 170:2274–2278.
2003.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Mabuchi T and Hirayama N: Binding affinity
and interaction of LL-37 with HLA-C*06:02 in psoriasis. J Invest
Dermatol. 1901–1903. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Qian L, Chen W, Sun W, Li M, Zheng R, Qian
Q and Lv L: Antimicrobial peptide LL-37 along with peptidoglycan
drive monocyte polarization toward CD14(high)CD16(+) subset and may
play a crucial role in the pathogenesis of psoriasis guttata. Am J
Transl Res. 7:1081–1094. 2015.PubMed/NCBI
|
|
12
|
Langley RG and Ellis CN: Evaluating
psoriasis with psoriasis area and severity index, psoriasis global
assessment, and lattice system physician's global assessment. J Am
Acad Dermatol. 51:563–569. 2004.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Fujisawa T, Murase K, Kanoh H, Takemura M,
Ohnishi H and Seishima M: Adsorptive depletion of
CD14+CD16+ proinflammatory monocyte phenotype
in patients with generalized pustular psoriasis: Clinical efficacy
and effects on cytokines. Ther Apher Dial. 16:436–444.
2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hyder LA, Gonzalez J, Harden JL,
Johnson-Huang LM, Zaba LC, Pierson KC, Eungdamrong NJ, Lentini T,
Gulati N, Fuentes-Duculan J, et al: TREM-1 as a potential
therapeutic target in psoriasis. J Invest Dermatol. 133:1742–1751.
2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ruiz-Romeu E, Ferran M, Giménez-Arnau A,
Bugara B, Lipert B, Jura J, Florencia EF, Prens EP, Celada A, Pujol
RM and Santamaria-Babí LF: MCPIP1 RNase is aberrantly distributed
in psoriatic epidermis and rapidly induced by IL-17A. J Invest
Dermatol. 136:1599–1607. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Owen CM, Chalmers RJ, O'sullivan T and
Griffiths CE: A systematic review of antistreptococcal
interventions for guttate and chronic plaque psoriasis. Br J
Dermatol. 145:886–890. 2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Owen CM, Chalmers R, O'Sullivan T and
Griffiths CE: WITHDRAWN: Antistreptococcal interventions for
guttate and chronic plaque psoriasis. Cochrane Database Syst Rev.
3(CD001976)2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hone SW, Donnelly MJ, Powell F and Blayney
AW: Clearance of recalcitrant psoriasis after tonsillectomy. Clin
Otolaryngol Allied Sci. 21:546–547. 1996.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Thorleifsdottir RH, Sigurdardottir SL,
Sigurgeirsson B, Olafsson JH, Sigurdsson MI, Petersen H, Arnadottir
S, Gudjonsson JE, Johnston A and Valdimarsson H: Improvement of
psoriasis after tonsillectomy is associated with a decrease in the
frequency of circulating T cells that recognize streptococcal
determinants and homologous skin determinants. J Immunol.
188:5160–5165. 2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Thorleifsdottir RH, Sigurdardottir SL,
Sigurgeirsson B, Olafsson JH, Sigurdsson MI, Petersen H, Gudjonsson
JE, Johnston A and Valdimarsson H: Patient-reported outcomes and
clinical response in patients with moderate-to-severe plaque
psoriasis treated with tonsillectomy: A randomized controlled
trial. Acta Derm Venereol. 97:340–345. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Rachakonda TD, Dhillon JS, Florek AG and
Armstrong AW: Effect of tonsillectomy on psoriasis: A systematic
review. J Am Acad Dermatol. 72:261–275. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Garritsen FM, Kraag DE and De Graaf M:
Guttate psoriasis triggered by perianal streptococcal infection.
Clin Exp Dermatol. 42:536–538. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Patrizi A, Costa AM, Fiorillo L and Neri
I: Perianal streptococcal dermatitis associated with guttate
psoriasis and/or balanoposthitis: A study of five cases. Pediatr
Dermatol. 11:168–171. 1994.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Herbst RA, Hoch O, Kapp A and Weiss J:
Guttate psoriasis triggered by perianal streptococcal dermatitis in
a four-year-old boy. J Am Acad Dermatol. 42:885–887.
2000.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yamamoto Y, Hashimoto A, Togashi K,
Takatsuka S and Ito M: Effects of treatment for dental focal
infection on pustulosis Palmaris et Plantaris. Jap J Dermatol.
111:821–826. 2001.
|
|
26
|
NG CY, Huang Y, Chu C, Wu T and Liu S:
Risks for Staphylococcus aureus colonization in psoriasis
patients: A systematic review and meta-analysis. Br J Dermatol.
177:967–977. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kenny K, Reiser R, Bastida F and Norcross
N: Production of enterotoxins and toxic shock syndrome toxin by
bovine mammary isolates of Staphylococcus aureus. J Clin
Microbiol. 31:706–707. 1993.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Tomi NS, Kränke B and Aberer E:
Staphylococcal toxins in patients with psoriasis, atopic
dermatitis, and erythroderma, and in healthy control subjects. J Am
Acad Dermatol. 53:67–72. 2005.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Göçmen JS, Şahiner N, Koçak M and Karahan
ZC: PCR investigation of Panton-valentine leukocidin, enterotoxin,
exfoliative toxin, and agr genes in Staphylococcus aureus
strains isolated from psoriasis patients. Turk J Med Sci.
45:1345–1352. 2015.PubMed/NCBI
|
|
30
|
Travers J, Hamid Q, Norris D, Kuhn C,
Giorno RC, Schlievert PM, Farmer ER and Leung DY: Epidermal HLA-DR
and the enhancement of cutaneous reactivity to superantigenic
toxins in psoriasis. J Clin Invest. 104:1181–1189. 1999.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Moriwaki Y, Takada K, Nagasaki T, Kubo N,
Ishii T, Kose K, Kageyama T, Tsuji S, Kawashima K and Misawa H:
IL-22/STAT3-induced increases in SLURP1 expression within psoriatic
lesions exerts antimicrobial effects against Staphylococcus
aureus. PLoS One. 10(e140750)2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Baker BS, Laman JD, Powles A, van der Fits
L, Voerman JS, Melief MJ and Fry L: Peptidoglycan and
peptidoglycan-specific ThI cells in psoriatic skin lesions. J
Pathol. 209:174–181. 2006.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Bianca B and Meyer TF: The human gastric
pathogen Helicobacter pylori and its association with
gastric cancer and ulcer disease. Ulcers. 2011(340157)2011.
|
|
34
|
Pellicano R, Ribaldone DG, Fagoonee S,
Astegiano M, Saracco GM and Mégraud F: A 2016 panorama of
Helicobacter pylori infection: Key messages for clinicians.
Panminerva Med. 58:304–137. 2016.PubMed/NCBI
|
|
35
|
Al-Mendalawi M: Screening of
Helicobacter pylori in patients with alopecia areata.
Menoufia Med J. 32(748)2019.
|
|
36
|
Xingzhe Y: Relationship between
Helicobacter pylori and rosacea: Review and discussion. BMC
Infect Dis. 18(318)2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Yu M, Zhang R, Ni P, Chen S and Duan G:
Helicobacter pylori infection and psoriasis: A systematic
review and meta-analysis. Medicina (Kaunas). 55(645)2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Testerman TL and Morris J: Beyond the
stomach: An updated view of Helicobacter pylori
pathogenesis, diagnosis, and treatment. World J Gastroenterol.
20:12781–12808. 2014.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Kao CY, Sheu BS, Sheu SM, Yang HB, Chang
WL, Cheng HC and Wu JJ: Higher motility enhances bacterial density
and inflammatory response in dyspeptic patients infected with
Helicobacter pylori. Helicobacter. 17:411–416.
2012.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Matysiak-Budnik T, Coffin B,
Lavergne-Slove A, Sabate JM, Mégraud F and Heyman M:
Helicobacter pylori increases the epithelial permeability to
a food antigen in human gastric biopsies. Am J Gastroenterol.
99:225–232. 2004.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Wang SK, Zhu HF, He BS, Zhang ZY, Chen ZT,
Wang ZZ and Wu GL: CagA+ H pylori infection is
associated with polarization of T helper cell immune responses in
gastric carcinogenesis. World J Gastroenterol. 13:2923–2931.
2007.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Magen E and Delgado JS: Helicobacter
pylori and skin autoimmune diseases. World J Gastroenterol.
20:1510–1516. 2014.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Radić M: Role of Helicobacter
pylori infection in autoimmune systemic rheumatic diseases.
World J Gastroenterol. 20:12839–12846. 2014.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Zaromb A, Chamberlain D, Schoor R, Almas K
and Blei F: Periodontitis as a manifestation of chronic benign
neutropenia. J Periodontol. 77:1921–1926. 2006.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Loos B: Systemic effects of periodontitis.
Ann R Australas Coll Dent Surg. 18:27–29. 2006.PubMed/NCBI
|
|
46
|
El-Shinnawi U and Soory M: Associations
between periodontitis and systemic inflammatory diseases: Response
to treatment. Recent Pat Endocr Metab Immune Drug Discov.
7:169–188. 2013.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Bunte K and Beikler T: Th17 Cells and the
IL-23/IL-17 Axis in the pathogenesis of periodontitis and
immune-mediated inflammatory diseases. Int J Mol Sci.
20(3394)2019.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Hirschfeld J, Higham J, Chatzistavrianou
D, Blair F, Richards A and Chapple ILC: Systemic disease or
periodontal disease? Distinguishing causes of gingival
inflammation: A guide for dental practitioners. Part 2: Cancer
related, infective, and other causes of gingival pathology. Br Dent
J. 227:1029–1034. 2019.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Leech M and Bartold PM: The association
between rheumatoid arthritis and periodontitis. Best Pract Res Clin
Rheumatol. 29:189–201. 2015.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Ungprasert P, Wijarnpreecha K and Wetter
DA: Periodontitis and risk of psoriasis: A systematic review and
meta-analysis. J Eur Acad Dermatol Venereol. 31:857–862.
2017.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Abdullah SN, Farmer EA, Spargo L, Logan R
and Gully N: Porphyromonas gingivalis peptidylarginine
deiminase substrate specificity. Anaerobe. 23:102–108.
2013.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Jenning M, Marklein B, Ytterberg J,
Zubarev RA, Joshua V, van Schaardenburg D, van de Stadt L, Catrina
AI, Nonhoff U, Häupl T, et al: Bacterial citrullinated epitopes
generated by Porphyromonas gingivalis infection-a missing
link for ACPA production. Ann Rheum Dis. 79:1194–1202.
2020.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Takahashi T and Yamasaki K: Psoriasis and
Antimicrobial Peptides. Int J Mol Sci. 21(6791)2020.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Sharma A, Raman A and Pradeep AR:
Association of chronic periodontitis and psoriasis: Periodontal
status with severity of psoriasis. Oral Dis. 21:314–319.
2015.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Zhang X, Gu H, Xie S and Su Y:
Periodontitis in patients with psoriasis: A systematic review and
meta-analysis. Oral Dis: Aug 27, 2020 (Epub ahead of print). doi:
10.1111/odi.13617.
|
|
56
|
Monson C: Periodontal aspects for
psoriasis: A systematic review. J Clin Res Dermatol. 3:1–8.
2016.
|
|
57
|
Skudutyte-Rysstad R, Slevolden EM, Hansen
BF, Sandvik L and Preus HR: Association between moderate to severe
psoriasis and periodontitis in a Scandinavian population. BMC Oral
Health. 14(139)2014.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Birkelund S, Johnsen H and Christiansen G:
Chlamydia trachomatis serovar L2 induces protein tyrosine
phosphorylation during uptake by HeLa cells. Infect Immun.
62:4900–4908. 1994.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Ferreri AJ, Dolcetti R, Dognini GP,
Malabarba L, Vicari N, Pasini E, Ponzoni M, Cangi MG, Pecciarini L,
Resti AG, et al: Chlamydophila psittaciis viable and infectious in
the conjunctiva and peripheral blood of patients with ocular
adnexal lymphoma: Results of a single-center prospective
case-control study. Int J Cancer. 123:1089–1093. 2008.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Ferreri AJ, Dolcetti R, Magnino S,
Doglioni C and Ponzoni M: Chlamydial infection: The link with
ocular adnexal lymphomas. Nat Rev Clin Oncol. 6:658–669.
2009.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Fabris M, De Vita S, Pasini E, Quartuccio
L, Pontarini E, Lombardi S, Fabro C, Sarzi-Puttini P, Pellerito R,
Benucci M, et al: Chlamydophila psittaci subclinical infection in
chronic polyarthritis. Clin Exp Rheumatol. 29:977–982.
2011.PubMed/NCBI
|
|
62
|
Stinco G, Fabris M, Pasini E, Pontarini E,
Patriarca MM, Piccirillo F, De Vita S and Dolcetti R: Detection of
DNA of Chlamydophila psittaci in subjects with psoriasis: A casual
or a causal link? Br J Dermatol. 167:926–928. 2012.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Rockey DD, Lenart J and Stephens RS:
Genome sequencing and our understanding of chlamydiae. Infect
Immun. 68:5473–5479. 2000.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Javad G, Taheri Sarvtin M, Hedayati MT,
Hajheydari Z, Yazdani J and Shokohi T: Evaluation of Candida
colonization and specific humoral responses against Candida
albicans in patients with atopic dermatitis. Biomed Res Int.
2015(849206)2015.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Rademaker M, Agnew K, Anagnostou N,
Andrews M, Armour K, Baker C, Foley P, Gebauer K, Gupta M, Marshman
G, et al: Psoriasis and infection. A clinical practice narrative.
Australas J Dermatol. 2:91–98. 2018.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Aşçioǧlu Ö, Soyuer Ü and Aktaş E:
Improvement of psoriasis with oral nystatin. In: Candida and
Candidamycosis. Federation of European Microbiological Societies
Symposium Series, vol 50. Tümbay E, Seeliger HPR and Anǧ Ö (eds).
Springer, Boston, MA pp279-281, 1991.
|
|
67
|
Fry L, Baker BS, Powles AV, Fahlen A and
Engstrand L: Is chronic plaque psoriasis triggered by microbiota in
the skin? Br J Dermatol. 169:47–52. 2013.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Lober CW, Belew PW, Rosenberg EW and Bale
G: Patch tests with killed sonicated microflora in patients with
psoriasis. Arch Dermatol. 5:322–325. 1982.PubMed/NCBI
|
|
69
|
Elewski B: Does Pityrosporum ovale have a
role in psoriasis? Arch Dermatol. 126:1111–1112. 1990.PubMed/NCBI
|
|
70
|
Farr PM, Krause LB, Marks JM and Shuster
S: Response of scalp psoriasis to oral ketoconazole. Lancet.
326:921–922. 1985.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Rosenberg EW and Belew PW: Improvement of
psoriasis of the scalp with ketoconazole. Arch Dermatol.
118:370–371. 1982.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Rudramurthy SM, Honnavar P, Chakrabarti A,
Dogra S, Singh P and Handa S: Association of Malassezia
species with psoriatic lesions. Mycoses. 57:483–838.
2014.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Gomez-Moyano E, Crespo-Erchiga V,
Martínez-Pilar L, Godoy Diaz D, Martínez-García S, Lova Navarro M
and Vera Casaño A: Do Malassezia species play a role in
exacerbation of scalp psoriasis? J Mycol Med. 24:87–92.
2014.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Baroni A, Paoletti I, Ruocco E, Agozzino
M, Tufano MA and Donnarumma G: Possible role of Malassezia
furfur in psoriasis: Modulation of TGF-beta1, integrin, and
HSP70 expression in human keratinocytes and in the skin of
psoriasis-affected patients. J Cutan Pathol. 31:35–42.
2004.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Yen YF, Jen IA, Chen M, Lan YC, Lee CY,
Chuang PH, Lee Y and Arthur Chen YM: HIV Infection increases the
risk of incident psoriasis: A nationwide population-based cohort
study in Taiwan. J Acquir Immune Defic Syndr. 75:493–499.
2017.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Goh BK, Chan RK, Sen P, Theng CT, Tan HH,
Wu YJ and Paton NI: Spectrum of skin disorders in human
immunodeficiency virus-infected patients in Singapore and the
relationship to CD4 lymphocyte counts. Int J Dermatol. 46:695–699.
2007.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Alpalhão M, Borges-Costa J and Filipe P:
Psoriasis in HIV infection: An update. Int J STD AIDS. 6:596–604.
2019.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Colebunders R, Blot K, Mertens V and Dockx
P: Psoriasis regression in terminal AIDS. Lancet.
339(1110)1992.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Roederer M, Dubs JG, Anderson MT, Raju PA
and Herzenberg LA and Herzenberg LA: CD8 naive T cell counts
decrease progressively in HIV-infected adults. J Clin Invest.
95:2061–2066. 1995.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Kim YH and Kim JW: The effect of calcium
on HLA-DR synthesis of cultured keratinocytes induced by
interferon-gamma. J Dermatol Sci. 1(382)1990.
|
|
81
|
Baker BS, Powles AV, Valdimarsson H and
Fry L: An altered response by psoriatic keratinocytes to gamma
interferon. Scand J Immunol. 28:735–740. 2006.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Terui T, Aiba S, Kato T, Tanaka T and
Tagami H: HLA-DR antigen expression on keratinocytes in highly
inflamed parts of psoriatic lesions. Br J Dermatol. 116:87–93.
1987.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Auböck J, Romani N, Grubauer G and Fritsch
P: HLA-DR expression on keratinocytes is a common feature of
diseased skin. Br J Dermatol. 114:465–472. 1986.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Townsley-Fuchs J, Neshat MS, Margolin DH,
Braun J and Goodglick L: HIV-1gp120: A novel viral B cell
superantigen. Int Rev Immunol. 14:325–338. 1997.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Torres BA and Johnson HM: Identification
of an HIV-1 Nef peptide that binds to HLA class II antigens.
Biochem Biophys Res Commun. 200:1065. 1994.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Fernandes S, Pinto GM and Cardoso J:
Particular clinical presentations of psoriasis in HIV patients. Int
J STD AIDS. 22:653–654. 2011.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Jain SP, Gulhane S, Pandey N and Bisne E:
Human papilloma virus infection and psoriasis: Did human papilloma
virus infection trigger psoriasis? Indian J Sex Transm Dis AIDS.
36:201–203. 2015.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Chen ML, Kao WM, Huang JY, Hung YM and Wei
CC: Human papillomavirus infection associated with increased risk
of new-onset psoriasis: A nationwide population-based cohort study.
Int J Epidemiol. 49:786–797. 2020.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Raychaudhuri SP, Jiang WY and Raychaudhuri
SK: Revisiting the Koebner phenomenon: Role of NGF and its receptor
system in the pathogenesis of psoriasis. Am J Pathol. 172:961–971.
2008.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Imafuku S and Nakayama J: Profile of
patients with psoriasis associated with hepatitis C virus
infection. J Dermatol. 40:428–433. 2013.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Di Nuzzo S, Boccaletti V, Fantini C,
Cortelazzi C, Missale G, Fabrizi G, Lotti T, Hercogová J and
Pagliarello C: Are Anti-TNF-α agents safe for treating psoriasis in
Hepatitis C virus patients with advanced liver disease? Case
reports and review of the literature. Dermatology. 232:102–106.
2015.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Farag AGA, Elshayb EE, Sharaky DRA,
Elashafey EN and Khadra AAEA: Role of HCV infection in psoriasis: A
clinical and immunohistochemical study. J Clin Diagnostic Res.
13:WC01–WC06. 2019.doi: 10.7860/JCDR/2019/39627.12833.
|
|
93
|
Chun K, Afshar M, Audish D, Kabigting F,
Paik A, Gallo R and Hata T: Hepatitis C may enhance key amplifiers
of psoriasis. J Eur Acad Dermatol Venereol. 4:672–678.
2016.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Young LS and Rickinson AB: Epstein-Barr
virus: 40 years on. Nat Rev Cancer. 4:757–768. 2004.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Neimann AL, Hodinka RL, Joshi YB, Elkan M
and Gelfand JM: Epstein-Barr virus and human herpesvirus type 6
infection in patients with psoriasis. Eur J Dermatol. 16:548–552.
2006.PubMed/NCBI
|
|
96
|
Loh E, Fung MA and Maverakis E: Acute
Guttate psoriasis in a 15-year-old girl with Epstein-Barr virus
infection. Arch Dermatol. 148:658–659. 2012.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Jiyad Z, Moriarty B, Creamer D and Higgins
E: Generalized pustular psoriasis associated with Epstein-Barr
virus. Clin Exp Dermatol. 40:164–168. 2015.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Yoneda K, Matsuoka-Shirahige Y, Demitsu T
and Kubota Y: Pustular psoriasis precipitated by cytomegalovirus
infection. Br J Dermatol. 167:1186–1189. 2012.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Ali FR, Green R, McMullen E, Motta L and
Judge MR: Cutaneous cytomegalovirus complicating pustular
psoriasis. Br J Dermatol. 71:670–671. 2014.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Yoneda K, Matsuoka-Shirahige Y, Demitsu T
and Kubota Y: Cytomegalovirus infection is one of the precipitating
factors for pustular psoriasis. J Dermatol Sci. 69(E38)2013.
|
|
101
|
Smith PD, Saini SS, Raffeld M,
Manischewitz JF and Wahl SM: Cytomegalovirus induction of tumor
necrosis factor-alpha by human monocytes and mucosal macrophages. J
Clin Invest. 90:1642–1648. 1992.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Marzouk S, S R, I S, N Z, Abdel Hay R and
M S: Role of cytomegalovirus infection and tumor necrosis factor-α
in psoriasis. J Egypt Wom Dermatol Soc. 34–39. 2009.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Arican O, Aral M, Sasmaz S and Ciragil P:
Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and
IL-18 in patients with active psoriasis and correlation with
disease severity. Mediators Inflamm. 2005:273–279. 2005.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Kirby B, Al-Jiffri O, Cooper RJ, Corbitt
G, Klapper PE and Griffiths CE: Investigation of cytomegalovirus
and human herpes viruses 6 and 7 as possible causative antigens in
psoriasis. Acta Derm Venereol. 80:404–406. 2000.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Ito T and Furukawa F: Psoriasis guttate
acuta triggered by varicella zoster virus infection. Eur J
Dermatol. 10:226–227. 2000.PubMed/NCBI
|
|
106
|
Zampetti A, Gnarra M, Linder D, Digiuseppe
MD, Carrino N and Feliciani C: Psoriatic pseudobalanitis circinata
as a post-viral koebner phenomenon. Case Rep Dermatol. 2:183–188.
2010.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Weitz M, Kiessling C, Friedrich M, Prösch
S, Höflich C, Kern F, Volk HD, Sterry W, Asadullah K and Döcke WD:
Persistent CMV infection correlates with disease activity and
dominates the phenotype of peripheral CD8+ T cells in
psoriasis. Exp Dermatol. 20:561–567. 2011.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Korzhova TP, Shyrobokov VP, Koliadenko VH,
Korniushenko OM, Akhramieieva NV and Stepanenko VI: Coxsackie B
viral infection in the etiology and clinical pathogenesis of
psoriasis. Likarska Sprava. 54–58. 2001.PubMed/NCBI(In Ukrainian).
|
|
109
|
Cabié A, Ledrans M and Abel S: Chikungunya
virus infections. N Engl J Med. 373(94)2015.
|
|
110
|
Sasaki Y, Manda S, Sato T, Maeda T,
Miyazaki T, Nakanishi K and Urita Y: Chikungunya virus infection
presenting with persistent arthralgia without fever. J Gen Family
Med. 16:204–207. 2015.
|
|
111
|
Riyaz N, Riyaz A, Rahima Abdul Latheef EN,
Anitha PM, Aravindan KP, Nair AS and Shameera P: Cutaneous
manifestations of chikungunya during a recent epidemic in Calicut,
north Kerala, south India. Indian J Dermatol Venereol Leprol.
76:671–676. 2010.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Inamadar AC, Palit A, Sampagavi VV,
Raghunath S and Deshmukh NS: Cutaneous manifestations of
chikungunya fever: Observations made during a recent outbreak in
south India. Int J Dermatol. 47:154–159. 2008.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Seetharam KA and Sridevi K: Chikungunya
infection: A new trigger for psoriasis. J Dermatol. 10:1033–1034.
2011.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Álvaro F, Juan C and Pilar M: Emergence
and spreading potential of Zika virus. Front Microbiol.
7(1667)2016.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Musso D and Gubler DJ: Zika virus. Clin
Microbiol Rev. 29(487)2016.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Paniz-Mondolfi AE, Rodriguez-Morales AJ,
Blohm G, Marquez M and Villamil-Gomez WE: ChikDenMaZika Syndrome:
The challenge of diagnosing arboviral infections in the midst of
concurrent epidemics. Ann Clin Microbiol Antimicrob.
15(42)2016.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Paniz Mondolfi AE, Hernandez Perez M,
Blohm G, Marquez M, Mogollon Mendoza A, Hernandez-Pereira CE,
Escalona MA, Lodeiro Colatosti A, Rothe DeArocha J and Rodriguez
Morales AJ: Generalized pustular psoriasis triggered by Zika virus
infection. Clin Exp Dermatol. 2:171–174. 2017.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Tappe D, Pérez-Girón JV, Zammarchi L,
Rissland J, Ferreira DF, Jaenisch T, Gómez-Medina S, Günther S,
Bartoloni A, Muñoz-Fontela C and Schmidt-Chanasit J: Cytokine
kinetics of Zika virus-infected patients from acute to
reconvalescent phase. Med Microbiol Immun. 205:269–273.
2016.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Yazici AC, Aslan G, Baz K, Ikizoglu G, Api
H, Serin MS, Tezcan S, Emekdas G and Tasdelen B: A high prevalence
of parvovirus B19 DNA in patients with psoriasis. Arch Dermatol
Res. 298:231–235. 2006.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Nakashima I, Fujihara K and Itoyama Y:
Human parvovirus B19 infection in multiple sclerosis. Eur Neurol.
42:36–40. 1999.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Page C, François C, Goëb V and Duverlie G:
Human parvovirus B19 and autoimmune diseases. Review of the
literature and pathophysiological hypotheses. J Clin Virol.
72:69–74. 2015.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Mehmet Y, Ceyhan AM, Arıdoğan BC, Koç İG
and Selçuk K: Investigation of relationship between parvovirus B19
infection and psoriasis. Turkderm. 44:49–50. 2010.
|
|
123
|
Fu Y, Cheng Y and Wu Y: Understanding
SARS-CoV-2-mediated inflammatory responses: From mechanisms to
potential therapeutic tools. Virol Sin. 35:266–271. 2020.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Kutlu Ö and Metin A: A case of
exacerbation of psoriasis after oseltamivir and hydroxychloroquine
in a patient with COVID-19: Will cases of psoriasis increase after
COVID-19 pandemic? Dermatol Ther. 33(e13383)2020.PubMed/NCBI View Article : Google Scholar
|
|
125
|
Vine JE, Hymes SR, Warner NB and Cohen PR:
Pustular psoriasis induced by hydroxychloroquine: A case report and
review of the literature. J Dermatol. 23:357–361. 1996.PubMed/NCBI
|
|
126
|
Gray RG: Hydroxychloroquine provocation of
psoriasis. J Rheumatol. 12(391)1985.PubMed/NCBI
|
|
127
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu
Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients
infected with 2019 novel coronavirus in Wuhan, China. Lancet.
395:497–506. 2020.PubMed/NCBI View Article : Google Scholar
|
|
128
|
Chung SD, Wang KH, Huang CC and Lin HC:
Scabies increased the risk of chronic kidney disease: A 5-year
follow-up study. J Eur Acad Dermatol Venereol. 28:286–292.
2014.PubMed/NCBI View Article : Google Scholar
|
|
129
|
He R, Gu X, Lai W, Peng X and Yang G:
Transcriptome-microRNA analysis of Sarcoptes scabiei and
host immune response. PLoS One. 12(e177733)2017.PubMed/NCBI View Article : Google Scholar
|
|
130
|
Arlian LG and Morgan MS: A review of
Sarcoptes scabiei: Past, present and future. Parasite
Vector. 10(297)2017.PubMed/NCBI View Article : Google Scholar
|
|
131
|
Keipert JA: Norwegian scabies in a girl
with psoriasis. Australas J Dermatol. 27:29–32. 1986.PubMed/NCBI View Article : Google Scholar
|
|
132
|
Liu JM, Lin CY, Chang FW, Liu YP, Liang CP
and Hsu RJ: Increased risk of psoriasis following scabies
infection: A nationwide population-based matched-cohort study. J
Dermatol. 3:302–308. 2018.PubMed/NCBI View Article : Google Scholar
|
|
133
|
Abd El-Aal AA, Hassan MA, Gawdat HI, Ali
MA and Barakat M: Immunomodulatory impression of anti and
pro-inflammatory cytokines in relation to humoral immunity in human
scabies. Int J Immunopathol Pharmacol. 29:188–194. 2016.PubMed/NCBI View Article : Google Scholar
|
|
134
|
Liu X, Walton SF, Murray HC, King M, Kelly
A, Holt DC, Currie BJ, McCarthy JS and Mounsey KE: Crusted scabies
is associated with increased IL-17 secretion by skin T cells.
Parasite Immunol. 36:594–604. 2014.PubMed/NCBI View Article : Google Scholar
|
|
135
|
Mounsey KE, Murray HC, Bielefeldt-Ohmann
H, Pasay C, Holt DC, Currie BJ, Walton SF and McCarthy JS:
Prospective study in a porcine model of Sarcoptes scabiei
indicates the association of Th2 and Th17 pathways with the
clinical severity of scabies. PLoS Negl Trop Dis.
9(e3498)2015.PubMed/NCBI View Article : Google Scholar
|
